LifeSplice Pharma is a biotechnology company that develops products for the treatment of neurological and non-neurological diseases. It offers splice-modulating oligomers (SMOs) that modulate dysregulated pre-mRNA splicing for neurological disorders. The company’s therapeutic areas include cancer, infectious diseases, and genetic disorders.